T3 Liothyronine Sodium + 5a-Hydroxy Laxogenin + SR-9011 + GW-0742 + Yohimbine Transdermal

$105.69

T3 Liothyronine Sodium + 5a-Hydroxy Laxogenin + SR-9011 + GW-0742 + Yohimbine Transdermal

 Original price was: $127.32.Current price is: $105.69.

Earn 106 points upon purchasing this product.

✅ 99% Purity – Third-Party Tested

🚚 Free U.S. Shipping on Orders $100+

🇺🇸 Proudly Made in the USA

⚡ Fast & Reliable Shipping

🔒 Secure Checkout Guaranteed

Enjoy 24/7 customer support, 1st & 3rd party verified 99% purity, and free shipping on orders over $100!

SKU: N/A Category:

T3 Liothyronine Sodium + 5a-Hydroxy Laxogenin + SR-9011 + GW-0742 + Yohimbine Transdermal – Product Information

T3 Liothyronine Sodium + 5a-Hydroxy Laxogenin + SR-9011 + GW-0742 + Yohimbine Transdermal is a research compound designed to explore the potential effects of its unique combination of T3 Liothyronine Sodium, 5a-Hydroxy Laxogenin, SR-9011, GW-0742, and Yohimbine. This formulation has a collective impact on various aspects of lipid metabolism and energy regulation in preclinical models.

The Ultimate Transdermal is strictly intended for research purposes.

  • The Transdermal consists of T3 Liothyronine Sodium, 5a-Hydroxy Laxogenin, SR-9011, GW-0742, and Yohimbine.
  • The Transdermal is offered as 50mcg T3 Liothyronine Sodium, 7.5mg 5a-Hydroxy Laxogenin, 5mg SR9011, 5mg GW0742, and 2.5mg Yohimbine, totaling 20mg per ml for 60ml or 1200mg in total.

T3 Liothyronine Sodium

Thyroid hormones, specifically T3 Liothyronine Sodium, have garnered interest in research due to their potential interactions with fat mass. A recent study conducted on rats explored the effects of T3 supplementation and found that it did not abolish the increased expression of thyroid hormone receptor beta, which occurs during caloric restriction. Additionally, T3 supplementation led to increased leptin gene expression.

The data suggest that T3 may not significantly elevate metabolic rate but rather mitigate the decline typically observed during prolonged caloric restriction in research models.

T3 Liothyronine Sodium Liquid
CAS Number 6893-02-3
Molar Mass 650,9735 g/mol
Chemical Formula C15H12I3NO4
IUPAC Name sodium;(2S)-2-amino-3-[4-(4-hydroxy-3-iodophenoxy)-3,5-diiodophenyl]propanoate 

5a-Hydroxy Laxogenin

5a-Hydroxy Laxogenin

Laxogenin, also known as 5 alpha hydroxy laxogenin or 5a hydroxy laxogenin, is a compound derived from plants and belongs to a group of compounds called brassinosteroids. While the exact mechanism of its effects is not yet fully understood, as a brassinosteroid, preliminary studies suggest its potential impact on increasing protein synthesis and reducing protein breakdown.

It is investigated for potential effects on protein synthesis and cortisol modulation in preclinical studies. Despite ongoing research, further investigation is needed to fully elucidate the mechanisms and potential benefits of laxogenin. It is important to note that this information is strictly related to research purposes.

5a-Hydroxy Laxogenin
CAS Number 56786-63-1
Molar Mass 446.6 g/mol
Chemical Formula C27H42O
IUPAC Name (1S,2S,4S,5’R,6R,7S,8R,9S,12S,13R,16S,18R)-16,18-dihydroxy-5′,7,9,13-tetramethylspiro[5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icosane-6,2′-oxane]-19-one

SR-9011

A recent study conducted on diet-induced obese mice investigated the effects of SR-9009 and SR-9011, administered twice daily for 30 days. The findings revealed a significant reduction in fat mass and notable improvements in dyslipidemia and hyperglycemia. Activation of REV-ERB, induced by these compounds, was observed to enhance the circadian rhythm in mice, impacting various aspects such as behavior, sleep cycles, and functions associated with increased energy production. These results offer valuable insights into the potential of SR9009 and SR-9011 in addressing obesity-related issues and optimizing metabolic function. It is important to note that this study was conducted for research purposes only.

SR-9011
CAS Number 1379686-29-9
Molar Mass 479.04 g/mol
Chemical Formula C23H31ClN4O3S
IUPAC Name 3-[[(4-chlorophenyl)methyl-[(5-nitrothiophen-2-yl)methyl]amino]methyl]-N-pentylpyrrolidine-1-carboxamide

GW-0742

GW-0742 is a PPARβ/δ agonist, which is being dubbed as a ‘Super Cardarine’. Studies have shown that GW0742 has the ability to improve glucose homeostasis and increase insulin sensitivity in diabetic rats. In diabetic rats fed a high fructose diet, a group given GW0742 showed lower blood sugar compared to the control group.

Due to GW0742 being a PPAR agonist, it showed the potential to be studied in research models for its effects on energy metabolism and fat utilization. This has been studied in research models for potential effects on energy metabolism and oxidative capacity in muscle tissue.

GW0742
CAS Number 317318-84-6
Molar Mass 471.48 g/mol
Chemical Formula C21H17F4NO3S2
IUPAC Name 2-[4-[[2-[3-fluoro-4-(trifluoromethyl)phenyl]-4-methyl-1,3-thiazol-5-yl]methylsulfanyl]-2-methylphenoxy]acetic acid

Yohimbine

Yohimbine is a compound derived from the bark of the Yohimbe tree (Pausinystalia yohimbe) and is of interest in research fields. It is classified as an alpha-2 adrenergic receptor antagonist, which means it blocks the action of these receptors. Yohimbine has been studied for its potential effects on various physiological processes. Preclinical studies show Yohimbine’s cardiovascular and adrenergic responses, and its potential to promote lipolytic activity in preclinical models.

 

Yohimbine
CAS Number 146-48-5
Molar Mass 354.450 g/mol
Chemical Formula C21H26N2O3
IUPAC Name 17α-hydroxy-yohimban-16α-carboxylic acid methyl ester 

Disclaimer

Disclaimer

This information is for educational purposes only and does not constitute medical advice. THE PRODUCTS DESCRIBED HEREIN ARE FOR LABORATORY AND RESEARCH USE ONLY. All clinical research must be conducted with oversight from the appropriate Institutional Review Board (IRB). All preclinical research must be conducted with oversight from the appropriate Institutional Animal Care and Use Committee (IACUC), following the guidelines of the Animal Welfare Act (AWA).

Our content is intended to be used and must be used for informational purposes only. It is very important to do your own analysis and research from Trusted Sources before making any purchase based on your own personal circumstances. You should independently research and verify any information that you find on our Website and wish to rely upon.

By completing and paying for your order, you agree to our Terms and Conditions. Customer satisfaction is our number one priority. If you are not 100% satisfied with the product you received, please contact us at support@purerawz.co

ATTENTION: All our products are for LABORATORY AND RESEARCH PURPOSES ONLY, not for veterinary or human usage.

Internal Links to Support T3 Liothyronine Sodium + 5a-Hydroxy Laxogenin + SR-9011 + GW-0742 + Yohimbine Transdermal for Sale

Related Research Compounds for T3 Liothyronine Sodium + 5a-Hydroxy Laxogenin + SR-9011 + GW-0742 + Yohimbine Transdermal

Trusted External Research Source for Advanced Transdermal Stack

Attribute

60ml/20mg per ml/1200mg

Reviews

There are no reviews yet.

Be the first to review “T3 Liothyronine Sodium + 5a-Hydroxy Laxogenin + SR-9011 + GW-0742 + Yohimbine Transdermal”

Your email address will not be published. Required fields are marked *

Scroll to Top